Latest Decheng Capital LLC Stock Portfolio
$731Million | No. of Holdings #14
Decheng Capital LLC Performance
2026 Q2+12.53%
YTD+5.62%
2025+68.98%
About Decheng Capital LLC and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Decheng Capital LLC reported an equity portfolio of $731.7 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of Decheng Capital LLC are , NUVB, . The fund has invested 61.9% of it's portfolio in CG ONCOLOGY INC and 20.1% of portfolio in NUVATION BIO INC. <br><br> The fund managers got completely rid off KRYSTAL BIOTECH INC (KRYS) stocks. They significantly reduced their stock positions in NEWAMSTERDAM PHARMA CO NV (NAMS), REVOLUTION MEDICINES INC(NSM) (RVMD) and ARCUS BIOSCIENCES, INC (RCUS). Decheng Capital LLC opened new stock positions in TANGO THERAPEUTICS INC (TNGX).
Decheng Capital LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$731Million
as of Aug 14, 2026Decheng Capital LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Decheng Capital LLC made a return of 12.53% in the last quarter. In trailing 12 months, it's portfolio return was 112.98%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| tango therapeutics inc | 625,200 |
New stocks bought by Decheng Capital LLC
Additions
No additions were made to existing positions by Decheng Capital LLC
Reductions
| Ticker | % Reduced |
|---|---|
| newamsterdam pharma co nv | -45.58 |
| revolution medicines inc(nsm) | -43.67 |
| arcus biosciences, inc | -2.73 |
Decheng Capital LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| krystal biotech inc | -1,885,740 |
Decheng Capital LLC got rid off the above stocks
Sector Distribution
Decheng Capital LLC has about 69.3% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 69.3 |
| Healthcare | 30.7 |
Market Cap. Distribution
Decheng Capital LLC has about 1.3% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MID-CAP
- SMALL-CAP
- MICRO-CAP
- LARGE-CAP
| Category | % |
|---|---|
| UNALLOCATED | 69.3 |
| MID-CAP | 22.2 |
| SMALL-CAP | 5.1 |
| MICRO-CAP | 2.1 |
| LARGE-CAP | 1.3 |
Stocks belong to which Index?
About 28.7% of the stocks held by Decheng Capital LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 71.3 |
| RUSSELL 2000 | 28.7 |
Decheng Capital LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Decheng Capital LLC
Decheng Capital LLC has 14 stocks in it's portfolio. About 98.1% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. NUVB was the most profitable stock for Decheng Capital LLC last quarter.
$731.75MTotal Value
15.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Aclaris Therapeutics, Inc. Decheng Capital LLC's holding in Aclaris Therapeutics, Inc. over time | 2.92% | 4,041,740 | $21.38M 2.92% | 0%unchanged 0 percentunchanged | |
 BYSI Beyondspring Inc.Beyondspring Inc.BYSI | 0.91% | 3,800,700 | $6.65M 0.91% | 0%unchanged 0 percentunchanged | |
 Equillium Inc. Decheng Capital LLC's holding in Equillium Inc. over time | 1.95% | 4,447,310 | $14.23M 1.95% | 0%unchanged 0 percentunchanged | |
 Krystal Biotech Inc Decheng Capital LLC's holding in Krystal Biotech Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Lyell Immunopharma, Inc. Decheng Capital LLC's holding in Lyell Immunopharma, Inc. over time | 1.33% | 692,050 | $9.72M 1.33% | 0%unchanged 0 percentunchanged | |
 NAMS Newamsterdam Pharma Co NvNewamsterdam Pharma Co NvNAMS | 0.82% | 176,887 | $5.99M 0.82% | 45.58%decreased 45.58 percentreduced | |
 Nuvation Bio Inc. Decheng Capital LLC's holding in Nuvation Bio Inc. over time | 20.15% | 25,954,400 | $147.42M 20.15% | 0%unchanged 0 percentunchanged | |
 Pyxis Oncology, Inc (Formerly Apexigen) Decheng Capital LLC's holding in Pyxis Oncology, Inc (Formerly Apexigen) over time | 0.13% | 326,810 | $983.7K 0.13% | 0%unchanged 0 percentunchanged | |
 Arcus Biosciences, Inc Decheng Capital LLC's holding in Arcus Biosciences, Inc over time | 1.96% | 464,779 | $14.33M 1.96% | 2.73%decreased 2.73 percentreduced | |
 Revolution Medicines Inc(Nsm) Decheng Capital LLC's holding in Revolution Medicines Inc(Nsm) over time | 1.35% | 52,667 | $9.86M 1.35% | 43.67%decreased 43.67 percentreduced | |
 Tango Therapeutics Inc Decheng Capital LLC's holding in Tango Therapeutics Inc over time | 0.09% | 20,000 | $625.2K 0.09% | Newnew position | |
 Zentalis Pharmaceuticals Inc. Decheng Capital LLC's holding in Zentalis Pharmaceuticals Inc. over time | 0.88% | 1,323,330 | $6.42M 0.88% | 0%unchanged 0 percentunchanged | |
Com Cg Oncology IncCg Oncology Inc | 61.87% | 6,371,670 | $452.71M 61.87% | 0%unchanged 0 percentunchanged | |
Com Aardvark Therapeutics IncAardvark Therapeutics Inc | 3.08% | 3,917,300 | $22.56M 3.08% | 0%unchanged 0 percentunchanged | |
Com Upstream Bio Inc.Upstream Bio Inc. | 2.58% | 2,724,870 | $18.86M 2.58% | 0%unchanged 0 percentunchanged | |